Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 8/20 | 1.00 |
| ▸ | SHBG | P04278 | 6/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 5/20 | 1.00 |
| ▸ | SERPINA6 | P08185 | 5/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 1.00 |
| ▸ | NR3C1 | P04150 | 4/20 | 1.00 |
| ▸ | BLM | P54132 | 4/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 1.00 |
| ▸ | MAPK3 | P27361 | 1/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.78 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.78 |
| ▸ | TSHR | P16473 | 4/20 | 0.78 |
| ▸ | PMP22 | Q01453 | 3/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.74 |
| ▸ | PGR | P06401 | 2/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydroxyprogesterone SCHEMBL30657985 | 1.00 | LMNA (1.00) | LMNASHBGCYP2C19SERPINA6SMN1; SMN2 | |
| Hydroxyprogesterone SCHEMBL18261234 | 1.00 | LMNA (1.00) | LMNASHBGCYP2C19SERPINA6SMN1; SMN2 | |
| Hydroxyprogesterone SCHEMBL265609 | 1.00 | LMNA (1.00) | LMNASHBGCYP2C19SERPINA6SMN1; SMN2 | |
| Hydroxyprogesterone SCHEMBL23456341 | 1.00 | LMNA (1.00) | LMNASHBGCYP2C19SERPINA6SMN1; SMN2 | |
| Hydroxyprogesterone SCHEMBL13558389 | 1.00 | LMNA (1.00) | LMNASHBGCYP2C19SERPINA6SMN1; SMN2 | |
| Hydroxyprogesterone SCHEMBL24287585 | 1.00 | LMNA (1.00) | LMNASHBGCYP2C19SERPINA6SMN1; SMN2 | |
| Hydroxyprogesterone SCHEMBL3931615 | 1.00 | LMNA (1.00) | LMNASHBGCYP2C19SERPINA6SMN1; SMN2 | |
| Hydroxyprogesterone SCHEMBL14523053 | 1.00 | LMNA (1.00) | LMNASHBGCYP2C19SERPINA6SMN1; SMN2 | |
| Hydroxyprogesterone SCHEMBL14546356 | 1.00 | LMNA (1.00) | LMNASHBGCYP2C19SERPINA6SMN1; SMN2 | |
| Hydroxyprogesterone SCHEMBL27048177 | 1.00 | LMNA (1.00) | LMNASHBGCYP2C19SERPINA6SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 20802 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260140124-A1 | PCOS STRATIFICATION | THE UNIVERSITY OF BIRMINGHAM (GB) | 2026-05-21 | — | — | US | claimed |
| CN-122042838-A | Application of gestational late urine metabolic marker of gestational diabetes and kit | 上海市第一人民医院 | 2026-05-15 | — | — | CN | claimed |
| EP-4740024-A1 | ENDOMETRIOSIS MARKERS AND METHODS OF DIAGNOSING ENDOMETRIOSIS | The University Court Of The University of Edinburgh (GB) | 2026-05-13 | — | — | EP | claimed |
| CN-122017085-A | Method for simultaneously detecting multiple steroid hormones in serum | 北京大学第三医院（北京大学第三临床医学院） | 2026-05-12 | — | — | CN | claimed |
| EP-4054407-B1 | STIMULATION DEVICES AND SYSTEMS | UNITED THERAPEUTICS CORP (US) | 2026-04-29 | — | — | EP | claimed |
| EP-4718073-A2 | MASS SPECTROMETRY ASSAY FOR CONGENITAL ADRENAL HYPERPLASIA | Quest Diagnostics Investments Incorporated (US) | 2026-04-01 | — | — | EP | claimed |
| EP-4718074-A2 | MASS SPECTROMETRY ASSAY FOR CONGENITAL ADRENAL HYPERPLASIA | Quest Diagnostics Investments Incorporated (US) | 2026-04-01 | — | — | EP | claimed |
| US-20260086089-A1 | DEVICE, METHOD AND SYSTEM FOR DIAGNOSING, MONITORING AND PREDICTING CHRONIC HEALTH CONDITIONS THROUGH URINE BIOMARKERS | HERSTASIS HEALTH FOUND (CA) | 2026-03-26 | — | — | US | claimed |
| EP-4712968-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA | Crinetics Pharmaceuticals, Inc. (US) | 2026-03-25 | — | — | EP | claimed |
| US-20260076872-A1 | POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME | SIO2 MEDICAL PRODUCTS LLC (US) | 2026-03-19 | — | — | US | claimed |
| EP-0001737-B1 | 17-ALPHA-(3-IODOBENZOYLOXY)-9-ALPHA-CHLORO-4-PREGNENE-3.20-DIONES, THEIR D-HOMO ANALOGUES AND PROCESS FOR THEIR PREPARATION | SCHERING AKTIENGESELLSCHAFT (DE) | 1981-01-07 | — | — | EP | claimed |
| US-4230684-A | RADIOIMMUNOASSAY | CORNELL RESEARCH FOUNDATION, INC. (US) | 1980-10-28 | — | — | US | claimed |
| US-4215691-A | Vaginal contraceptive system made from block copolymer | ALZA CORPORATION (US) | 1980-08-05 | — | — | US | claimed |
| US-4177269-A | ANTITUMOR AGENTS | AKTIEBOLAGET LEO (SE) | 1979-12-04 | — | — | US | claimed |
| US-4150105-A | 3-Ketosteroid antigenic conjugates, their preparation, antibodies and use | BIOLOGICAL DEVELOPMENTS, INC. (US) | 1979-04-17 | — | — | US | claimed |
| US-4093709-A | Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates) | ALZA CORPORATION (US) | 1978-06-06 | — | — | US | claimed |
| US-4016270-A | Method for treating dysmenorrhea with a uterine therapeutic system | ALZA CORPORATION (US) | 1977-04-05 | — | — | US | claimed |
| US-4016251-A | Vaginal drug dispensing device | ALZA CORPORATION (US) | 1977-04-05 | — | — | US | claimed |
| US-4014987-A | VAGINAL DEVICE; USING A HYDROPHOBIC POLYCARBOXYLIC ACID AS DRUG RELEASE RATE CONTROLLER | ALZA CORPORATION (US) | 1977-03-29 | — | — | US | claimed |
| US-4014988-A | Method for treating hypermenorrhea with uterine therapeutic system | ALZA CORPORATION (US) | 1977-03-29 | — | — | US | claimed |